COc1cc2oc(-c3ccc(O)cc3)c(OC3OC(C)C(O)C(O)C3O)c(=O)c2c(O)c1OC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?